Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Creutzberg, C.L.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(49 - 72 of 196)

Pages

PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
Management of conjunctival melanoma with local excision and adjuvant brachytherapy
Implementing clinical practice guidelines: time to assess it
Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Uterine Cancer: Adjuvant Therapy and Management of Metastatic Disease
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3)
A Transcriptionally Distinct CXCL13(+)CD103(+)CD8(+) T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature
Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer
Gynecological cancers translational, research implementation, and harmonization
Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
Cancer of the corpus uteri
Differences in health care professionals' and cancer patients' views on sexual health issues
Ruthenium-106 brachytherapy for iris and iridociliary melanomas
ESGO Survey on Current Practice in the Management of Cervical Cancer
Adjuvant Treatment for POLE Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?
Treatment toxicity in endometrial cancer: can we identify and manage it better?
ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial

Pages